BGLC
BioNexus Gene Lab Corp.
NASDAQ · Healthcare · Medical - Diagnostics & Research · MY
$1.41
−4.08%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.53x
- Price / sales
- 1.32x
- Price / cash flow
- -4.91x
Enterprise value
- Enterprise value
- $813.2K
- EV / sales
- 0.26x
- EV / EBITDA
- -0.33x
- EV / EBIT
- -0.31x
- Market cap
- $4.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026